These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 15882063

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1.
    VanCott TC, Bethke FR, Polonis VR, Gorny MK, Zolla-Pazner S, Redfield RR, Birx DL.
    J Immunol; 1994 Jul 01; 153(1):449-59. PubMed ID: 7515931
    [Abstract] [Full Text] [Related]

  • 24. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP, Bennett AE, Zvi A, Anglister J, Steinbach PJ, Tycko R.
    Nat Struct Biol; 1999 Feb 01; 6(2):141-5. PubMed ID: 10048925
    [Abstract] [Full Text] [Related]

  • 25. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H, Usami O, Xiao P, Gu HX, Hattori T.
    AIDS Res Hum Retroviruses; 2004 Feb 01; 20(2):213-8. PubMed ID: 15018709
    [Abstract] [Full Text] [Related]

  • 26. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
    Gorny MK, VanCott TC, Hioe C, Israel ZR, Michael NL, Conley AJ, Williams C, Kessler JA, Chigurupati P, Burda S, Zolla-Pazner S.
    J Immunol; 1997 Nov 15; 159(10):5114-22. PubMed ID: 9366441
    [Abstract] [Full Text] [Related]

  • 27. NMR evidence of charge-dependent interaction between various PND V3 and CCR5 N-terminal peptides.
    Galanakis PA, Kandias NG, Rizos AK, Morikis D, Krambovitis E, Spyroulias GA.
    Biopolymers; 2009 Nov 15; 92(2):94-109. PubMed ID: 19117029
    [Abstract] [Full Text] [Related]

  • 28. NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
    Tsang P, Mu X, Wu G, Durda PJ.
    J Mol Recognit; 1997 Nov 15; 10(6):256-61. PubMed ID: 9770649
    [Abstract] [Full Text] [Related]

  • 29. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
    Andrianov AM.
    Tsitologiia; 2006 Nov 15; 48(11):948-57. PubMed ID: 17233480
    [Abstract] [Full Text] [Related]

  • 30. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S.
    J Immunol; 1993 Jan 15; 150(2):635-43. PubMed ID: 7678279
    [Abstract] [Full Text] [Related]

  • 31. Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.
    Dutta M, Liu J, Roux KH, Taylor KA.
    J Virol; 2014 Nov 15; 88(21):12265-75. PubMed ID: 25122783
    [Abstract] [Full Text] [Related]

  • 32. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.
    Nara P, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Krone W, Goudsmit J.
    Dev Biol Stand; 1990 Nov 15; 72():315-41. PubMed ID: 2282990
    [Abstract] [Full Text] [Related]

  • 33. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW.
    PLoS Pathog; 2007 Aug 24; 3(8):e117. PubMed ID: 17722977
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD, Schellekens MM, Lewis GK, Moore JP, Matthews TJ, Langedijk JP, Meloen RH, Boersma WJ, Claassen E.
    AIDS Res Hum Retroviruses; 1993 Jul 24; 9(7):605-12. PubMed ID: 8369165
    [Abstract] [Full Text] [Related]

  • 38. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q, Napier KB, Trent JO, Wang Z, Taylor S, Griffin GE, Peiper SC, Shattock RJ.
    J Mol Biol; 2005 Jul 22; 350(4):699-712. PubMed ID: 15964018
    [Abstract] [Full Text] [Related]

  • 39. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR, Strick N, Debnath AK.
    J Mol Recognit; 1995 Jul 22; 8(6):345-57. PubMed ID: 9052975
    [Abstract] [Full Text] [Related]

  • 40. Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.
    Kirby KA, Ong YT, Hachiya A, Laughlin TG, Chiang LA, Pan Y, Moran JL, Marchand B, Singh K, Gallazzi F, Quinn TP, Yoshimura K, Murakami T, Matsushita S, Sarafianos SG.
    FASEB J; 2015 Jan 22; 29(1):70-80. PubMed ID: 25351987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.